Last week, Gilead Sciences announced pricing for its breakthrough Covid-19 drug remdesivir (brand name Veklury) approved by the FDA for emergency use in May. The company announced it will charge…
Stay informed with Paul’s unique perspective on healthcare happenings, from policies and politics to innovations and investments. Subscribe today to the Keckley Report and be the first to receive Paul’s weekly insights and special reports.